Clinical Trials Logo

Substance-Related Disorders clinical trials

View clinical trials related to Substance-Related Disorders.

Filter by:

NCT ID: NCT00230022 Completed - Clinical trials for Substance-Related Disorders

Pilot Clinical Trial of Computer-based Motivational Intervention - 1

Start date: October 2004
Phase: Phase 1
Study type: Interventional

Pilot trial of computer-based motivational intervention. Hypothesis: The brief computer-delivered intervention would result in higher motivation to change at follow-up.

NCT ID: NCT00229983 Completed - Clinical trials for Substance-Related Disorders

Medical Office Intervention for Adolescent Drug Use

Start date: June 2004
Phase: Phase 2
Study type: Interventional

The goal of this study is to assess the efficacy of a new intervention based on motivational enhancement therapy among adolescents with a history of substance use.

NCT ID: NCT00228007 Completed - Depression Clinical Trials

Antidepressant Medication for Reducing HIV Risk Behavior in Depressed Intravenous Drug Users

Start date: September 2000
Phase: Phase 3
Study type: Interventional

This study will evaluate the effectiveness of antidepressant medication treatment in reducing HIV risk behaviors in intravenous drug users with depression.

NCT ID: NCT00227877 Completed - Clinical trials for Substance Related Disorders

Screening and Brief Advice to Reduce Teen Substance Use

Start date: December 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to test the effectiveness of a brief intervention for alcohol and drug use in adolescents that a primary care doctor can give in his/her office. The study will be conducted in nine primary care offices in three New England states, and in ten pediatric offices in Prague, Czech Republic (CZR). We hypothesize that: 1. Among 12-18 year old well care patients who screen positive for drug/alcohol use, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing drug and alcohol use; 2. Among 12-18 year old well care patients who screen negative for drug/alcohol use, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing initiation of drug and alcohol use as measured by self-reports of substance use; 3. Among 12-18 year old well care patients who are at risk for riding with an impaired driver or driving while impaired, the experimental intervention administered by trained primary care providers will be more effective than standard care in decreasing Riding/Driving risk behavior as measured by a standardized scale.

NCT ID: NCT00227838 Completed - Bipolar Disorder Clinical Trials

Modifying Group Therapy for Bipolar Substance Abusers - 1

Start date: July 2003
Phase: N/A
Study type: Interventional

The purpose of this study is to modify Integrated Group Therapy (IGT), which is has been found successful for patients with bipolar disorder (BD) and substance use disorder(SUD), so that it can be more readily adopted by community drug abuse treatment programs. IGT is being reduced from 20 to 12 sessions in this trial, and is being conducted by front-line drug counselors, to test its effectiveness in a more community-based setting. The training has been expanded so that counselors without much psychopathology training or cognitive behavioral therapy experience can conduct IGT.

NCT ID: NCT00223197 Completed - Clinical trials for Major Depressive Disorder

Pregnenolone Trial for Depression in Bipolar Disorders or Recurrent Major Depressive Disorder With Substance Abuse

Start date: February 2004
Phase: Phase 4
Study type: Interventional

The purpose of this research is to determine if pregnenolone supplement is associated with a reduction in substance use and craving in patients with recurrent major depressive disorder or bipolar disorder and substance abuse/dependence. This research also wants to explore if pregnenolone supplements are associated with improvement in psychiatric symptoms and memory, which are often negatively affected in these patients. It is hypothesized that patients receiving pregnenolone supplements would show greater improvements in mood symptoms and memory, and crave substances less than the patients receiving placebo.

NCT ID: NCT00218725 Completed - Clinical trials for Substance-Related Disorders

Effectiveness of Cognitive Therapy for Suicide Attempters With Drug Dependence Disorder

Start date: May 2005
Phase: Phase 1
Study type: Interventional

This study will examine the effectiveness of combining cognitive therapy with enriched usual care for preventing subsequent suicide attempts in people with a drug dependence who have recently attempted suicide.

NCT ID: NCT00218634 Completed - Depression Clinical Trials

Skills Based Counseling for Adherence and Depression in HIV+ Methadone Patients - 1

Start date: February 2005
Phase: N/A
Study type: Interventional

Patients with HIV, depression, and opioid-dependence are at high risk for poor health outcomes. This is a two-arm randomized controlled trial of cognitive-behavioral therapy for depression and HIV medication adherence in patients with opioid dependence who are receiving methadone maintenance treatment. The project is based on our pilot work with close attention to NIDA guidelines for a staged approach to treatment development and testing (Rounsaville et al., 2001). Depression is highly comorbid with both HIV infection and with opioid dependence. Depression and substance abuse are both associated with poor adherence to antiretroviral medications. Patients with HIV, depression, and opioid dependence are at high risk for poor health outcomes. Cognitive-behavioral therapy is the most widely studied and efficacious psychosocial intervention for depression; and research by the PI and others has shown that cognitive-behavioral interventions have been successful in promoting adherence to HIV medications.

NCT ID: NCT00218582 Completed - Clinical trials for Substance-Related Disorders

Effectiveness of Self-Help for Dually-Diagnosed Persons - 1

Start date: March 2003
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine the effectiveness of adding dual focus 12-step self-help groups to standard treatment to improve behavioral outcomes for patients dually diagnosed with substance abuse and psychiatric disorders.

NCT ID: NCT00218322 Completed - Clinical trials for Substance-Related Disorders

Effectiveness of ATMX in Treating Adolescents With ADHD and SUD

Start date: September 2004
Phase: Phase 4
Study type: Interventional

Adolescents with attention deficit hyperactivity disorder (ADHD) often develop substance use disorders (SUD). The purpose of this study is to evaluate the effectiveness of atomoxetine in treating adolescents dually diagnosed with ADHD and SUD.